缺失自我诱导的移植肾微血管排斥:一项基于人群的研究
该研究纳入924例肾移植受者,进行供受者高分辨率HLA分型和受者KIR基因分型,发现399例存在缺失自我,且两种缺失自我类型共存时微血管炎症风险独立于HLA-DSA增加(HR 1.78),缺失自我与移植肾小球病相关(HR 2.51),但移植物存活优于HLA-DSA相关微血管炎症。
要点
- 缺失自我是独立于HLA-DSA的微血管炎症触发因素,两种类型共存时风险增加。
- HLA-DSA阴性微血管炎症受者中部分存在缺失自我,提示非体液机制。
- 缺失自我与移植肾小球病相关,但移植物存活优于HLA-DSA相关微血管炎症。
核心结论
- 缺失自我特异性且累积性增加肾移植后微血管炎症风险,独立于HLA-DSA。
- 系统评估缺失自我有助于理解HLA-DSA阴性微血管炎症,可能改善诊断分类和风险分层。
研究设计与样本
- 基于人群的队列研究,纳入2004年3月至2013年2月间连续924例肾移植。
- 进行供受者高分辨率HLA分型和受者KIR基因分型。
- 缺失自我定义为供者缺乏A3/A11、Bw4、C1或C2基因型,且受者存在相应教育性抑制性KIR基因。
主要发现
- 924例移植中识别出399例存在缺失自我。
- 缺失自我类型共存对微血管炎症风险有累积效应,两种类型共存时风险比(HR)为1.78(95%CI 1.26-2.53),独立于HLA-DSA(HR 5.65,95%CI 4.01-7.96)。
- 缺失自我与细胞性排斥病变无关联。
- 222例微血管炎症受者中146例检测不到HLA-DSA,其中28例存在至少两种缺失自我类型。
- 缺失自我与微血管炎症后移植肾小球病相关(HR 2.51,95%CI 1.12-5.62),但移植物存活优于HLA-DSA相关微血管炎症。
临床怎么用
- 对肾移植受者进行缺失自我评估可能有助于识别HLA-DSA阴性微血管炎症的风险。
- 缺失自我与HLA-DSA联合评估可用于患者风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Circulating anti-HLA donor-specific antibodies (HLA-DSA) are often absent in kidney transplant recipients with microvascular inflammation (MVI). Missing self, the inability of donor endothelial cells to provide HLA I-mediated signals to inhibitory killer cell Ig-like receptors (KIRs) on recipient natural killer cells, can cause endothelial damage in vitro, and has been associated with HLA-DSA-negative MVI. However, missing self's clinical importance as a nonhumoral trigger of allograft rejection remains unclear. METHODS: In a population-based study of 924 consecutive kidney transplantations between March 2004 and February 2013, we performed high-resolution donor and recipient HLA typing and recipient KIR genotyping. Missing self was defined as the absence of A3/A11, Bw4, C1, or C2 donor genotype, with the presence of the corresponding educated recipient inhibitory KIR gene. RESULTS: We identified missing self in 399 of 924 transplantations. Co-occurrence of missing self types had an additive effect in increasing MVI risk, with a threshold at two concurrent types (hazard ratio [HR], 1.78; 95% confidence interval [95% CI], 1.26 to 2.53), independent of HLA-DSA (HR, 5.65; 95% CI, 4.01 to 7.96). Missing self and lesions of cellular rejection were not associated. No HLA-DSAs were detectable in 146 of 222 recipients with MVI; 28 of the 146 had at least two missing self types. Missing self associated with transplant glomerulopathy after MVI (HR, 2.51; 95% CI, 1.12 to 5.62), although allograft survival was better than with HLA-DSA-associated MVI. CONCLUSION: Missing self specifically and cumulatively increases MVI risk after kidney transplantation, independent of HLA-DSA. Systematic evaluation of missing self improves understanding of HLA-DSA-negative MVI and might be relevant for improved diagnostic classification and patient risk stratification.
引用
- Callemeyn J, Senev A, Coemans M, et al. Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study. J Am Soc Nephrol. 2021. PMID: 34301794. doi:10.1681/ASN.2020111558
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。